Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2025-09-15
2026-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the study OCT2ACT is to investigate:
* The main reasons/barriers limiting the use of intracoronary imaging in complex PCI cases where it is indicated as suggested by guidelines;
* The main reasons behind the selection of IVUS or OCT in such patients;
* In cases where OCT is used, how this technology can influence the procedural planning and optimization in complex clinical settings.
The participating centers will include three cohorts of patients:
1. Cohort intracoronary imaging NO: patients who meet the inclusion/exclusion criteria, but did not undergo intracoronary imaging (IVUS or OCT) due to operator's decision.
The aim is to describe the main reasons/barriers for not using imaging.
2. Cohort intracoronary imaging YES according to guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging as recommended by guidelines.
The aim is to understand the main reasons for the decision to use IVUS or OCT and the clinical benefits perceived by the operator.
3. Cohort intracoronary imaging YES outside guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging (IVUS or OCT) outside.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of OCT Imaging on Decision Making During PCI in ACS Patients
NCT04444037
Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study
NCT03646097
Optical Coherence Tomography in Acute Coronary Syndrome
NCT03129503
Observational Study of Angiographic Coregistered Optical Coherence Tomography in Patients Undergoing PCI
NCT02919943
Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study
NCT01239654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This strong level of recommendation is based on the recent evidence that intracoronary imaging reduces the incidence of hard clinical endpoints, including mortality, as compared to conventional angiography alone.
Yet, there is compelling evidence documenting the under-utilization of IVUS and OCT in daily practice. Many potential reasons, including time, costs, limited availability of technology, expertise of the operators have been suggested. However, no specific study investigated the reasons behind this malpractice. In particular, these reasons should be investigated now that intracoronary imaging has been upgraded to class I recommendation and that many technologies are available significantly reducing the economic burden. In addition, there are some particular anatomic subsets where OCT could be particularly helpful (bifurcations, severe calcification, acute coronary syndrome patients) and it could be interesting to assess the penetration of this technology in this subset of patients. Finally, these devices can be used also in anatomical subsets (diagnosis and procedural guidance) outside from Guidelines recommendations and it is important to assess their safety and clinical advantage in this setting.
Objective
The OCT2ACT study aims to investigate:
* The main reasons/barriers limiting the use of intracoronary imaging in complex PCI where it is indicated as suggested by guidelines
* The main reasons behind the selection of IVUS or OCT in complex PCI
* In complex PCI guided by OCT, How OCT can influence the procedural planning and optimization in complex clinical settings.
The OCT2ACT is an observational, prospective, multicenter, investigator-driven study.
Participating centers will include three different cohorts of patients:
1. Cohort intracoronary imaging NO In this cohort, the investigators will include all the patients matching inclusion/exclusion criteria, but in whom intracoronary imaging (IVUS or OCT) was not used (operator's decision). The aim is to have a description of the main reasons/barriers that led to the avoidance of imaging utilization.
2. Cohort intracoronary imaging YES according to guidelines recommendation In this cohort, the investigators will include all the patients matching inclusion/exclusion criteria in whom intracoronary imaging (IVUS or OCT) was used (operator's decision) according to guidelines recommendation. The aim is to understand the main reasons behind the decision to use IVUS or OCT and the clinical advantages perceived by the operators.
3. Cohort intracoronary imaging YES outside guidelines recommendation In this cohort, the investigators will include all the patients matching inclusion/exclusion criteria in whom OCT was used (operator's decision) outside Guidelines recommendations. The aim is to understand the main reasons behind the decision to use OCT outside guidelines recommendation, its safety and the clinical advantages perceived by the operators.
After Ethic Committee approval and site initiation visit, each participating center will recruit consecutive patients for a time window of 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort intracoronary imaging NO
• Inclusion criteria
Patients undergoing clinically indicated PCI and having at least one of the following criteria (suggestive for complex PCI) without receiving intracoronary imaging:
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
• Exclusion criteria
* Refusal of informed consent
No interventions assigned to this group
Cohort intracoronary imaging YES according to guidelines recommendation
• Inclusion criteria
Patients undergoing clinically indicated PCI with the guidance of intracoronary imaging (OCT or IVUS) and having at least one of the following criteria (suggestive for complex PCI) receiving imaging:
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
• Exclusion criteria
* Refusal of informed consent
No interventions assigned to this group
Cohort intracoronary imaging YES outside guidelines recommendation
* Inclusion criteria Patients undergoing IVUS or OCT use.
* Exclusion criteria
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
* Refusal of informed consent
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
Patients undergoing clinically indicated PCI with the guidance of intracoronary imaging (OCT or IVUS) and having at least one of the following criteria (suggestive for complex PCI) receiving imaging:
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
Exclusion Criteria
2. Cohort intracoronary imaging YES according to guidelines recommendation
* Refusal of informed consent
3. Cohort intracoronary imaging YES outside guidelines recommendation
* Long lesion (\>38 mm)
* True bifurcation involving side-branch with a reference diameter of \>2.5 mm and Medina 1.1.1
* Left main bifurcation
* Refusal of informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorzio Futuro in Ricerca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Biscaglia
Role: STUDY_CHAIR
Azienda Ospedaliero Universitaria di Ferrara
Vergallo Rocco
Role: PRINCIPAL_INVESTIGATOR
Ospedale Policlinico San Martino
Paolo Canova
Role: PRINCIPAL_INVESTIGATOR
ASST Papa Giovanni XXIII, Bergamo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST Papa Giovanni XXIII
Bergamo, , Italy
Ospedale San Martino
Genova, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S; ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCT2ACT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.